Articles & Insights
The Two-Minute Rule
July 9, 2026

Shared-risk and bundled IVF programs vary in the details, but most fall into a few shapes:
What patients are buying, in all of these structures, is financial certainty in a process that offers very little of it. More than 70% of patients require more than one cycle to achieve success (source), and the prospect of paying $25,000, getting nothing, and then paying another $25,000 is one of the most paralyzing financial conversations in healthcare. Bundled and shared-risk programs replace that uncertainty with a fixed cost and a known worst case.
The pricing model is straightforward. The billing infrastructure underneath it is not.
A few common pressure points:
When the billing system can't handle these structures natively, groups end up running shared-risk programs on spreadsheets. That works, until it doesn't.
The hidden cost of running flexible payment programs on inflexible billing infrastructure is real. It shows up as:
There is also a competitive cost. Groups that can't operationalize shared-risk programs cleanly often choose not to offer them, while their peers do. Patients who are shopping for fertility care, especially in premium markets, increasingly expect the option.
It is worth slowing down to look at how this fails from the patient's perspective, because that is where the group actually loses the relationship.
Consider a patient who paid $25,000 upfront for a three-cycle shared-risk package. Her first cycle didn't result in a live birth, and she is now looking at her financial picture across multiple events. She paid a single sum upfront, but her first cycle generated bills from multiple entities: the group, the genetics lab, the specialty pharmacy. She has used some of her bundled cycles but not all. She has accumulated a credit from a cancelled FET. She has a question about whether her medication coverage from the bundle has been applied correctly.
If the billing system shows her a clean, consolidated view of where she stands inside her program, she stays engaged and trusts the group. If she has to stitch the picture together from three different statements, two phone calls, and a spreadsheet she keeps herself, the relationship is on borrowed time. Patients in shared-risk programs are, by definition, deeply financially invested. Their tolerance for billing confusion is the lowest of any cohort the group serves.
The right infrastructure makes the back end of shared-risk programs invisible to both the patient and the billing team. In practice, that means:
The patient never needs to think about any of this. The billing team does the strategic work of program design, not the manual labor of program administration.
The collection-rate math reinforces why getting this right is operationally critical. Industry data shows collection rates for balances of $5,000 to $7,500 fall to around 32%, and balances above $7,500 collect at just 17% (source). Bundled programs essentially eliminate that collection risk by moving payment upfront, but only if the underlying billing engine can handle the resulting complexity without creating new failure points.
There is also a market signal worth attending to. 62% of consumers want to discuss payment plan or financing options before the procedure, not after the bill arrives (source). Shared-risk and bundle programs are essentially that conversation made operational. Groups that offer them, and run them cleanly, are responding to a clear, documented patient demand.
PatientPay's payment engine is designed for high-dollar, multi-payer, multi-event healthcare environments. Upfront payments, milestone-based plans, refunds, and account credits all run inside the same platform that handles ongoing patient billing, which means a group can offer the financial products patients want without bolting together separate systems to manage them.
The shared-risk model is a financial design choice. The billing infrastructure that supports it is a strategic capability.
See how PatientPay supports flexible fertility payment programs →